360 NEWS360 NEWS

Healthcare ยท National

FDA adds rare vision-loss warning to popular obesity, diabetes drugs

The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss and has been reported with all GLP-1 drugs,

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on โ€œFDA adds rare vision-loss warning to popular obesity, diabetes drugsโ€?

This is self-selected reader participation, not representative scientific polling.